Literature DB >> 29421034

Stereoselective hydroxylation of isophorone by variants of the cytochromes P450 CYP102A1 and CYP101A1.

Shaghayegh Dezvarei1, Joel H Z Lee1, Stephen G Bell2.   

Abstract

The stereoselective oxidation of hydrocarbons is an area of research where enzyme biocatalysis can make a substantial impact. The cyclic ketone isophorone was stereoselectively hydroxylated (≥95%) by wild-type CYP102A1 to form (R)-4-hydroxyisophorone, an important chiral synthon and flavour and fragrance compound. CYP102A1 variants were also selective for 4-hydroxyisophorone formation and the product formation rate increased over the wild-type enzyme by up to 285-fold, with the best mutants being R47L/Y51F/I401P and A74G/F87V/L188Q. The latter variant, which contained mutations in the distal substrate binding pocket, was marginally less selective. Combining perfluorodecanoic acid decoy molecules with the rate accelerating variant R47L/Y51F/I401P engendered further improvement with the purified enzymes. However when the decoy molecules were used with A74G/F87V/L188Q the amount of product generated by the enzyme was reduced. Addition of decoy molecules to whole-cell turnovers did not improve the productivity of these CYP102A1 systems. WT CYP101A1 formed significant levels of 7-hydroxyisophorone as a minor product alongside 4-hydroxyisophorone. However the F87W/Y96F/L244A/V247L CYP101A1 mutant was ≥98% selective for (R)-4-hydroxyisophorone. A comparison of the two enzyme systems using whole-cell oxidation reactions showed that the best CYP101A1 variant was able to generate more product. We also characterised that the further oxidation metabolite 4-ketoisophorone was produced and then subsequently reduced to levodione by an endogenous Escherichia coli ene reductase.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytochrome P450; Hydroxylation; Isophorone; Regioselective; Stereoselective

Mesh:

Substances:

Year:  2018        PMID: 29421034     DOI: 10.1016/j.enzmictec.2018.01.002

Source DB:  PubMed          Journal:  Enzyme Microb Technol        ISSN: 0141-0229            Impact factor:   3.493


  3 in total

Review 1.  A Promiscuous Bacterial P450: The Unparalleled Diversity of BM3 in Pharmaceutical Metabolism.

Authors:  Sian Thistlethwaite; Laura N Jeffreys; Hazel M Girvan; Kirsty J McLean; Andrew W Munro
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

2.  A 96-multiplex capillary electrophoresis screening platform for product based evolution of P450 BM3.

Authors:  Anna Gärtner; Anna Joëlle Ruff; Ulrich Schwaneberg
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

3.  Introducing an Artificial Deazaflavin Cofactor in Escherichia coli and Saccharomyces cerevisiae.

Authors:  Misun Lee; Jeroen Drenth; Milos Trajkovic; René M de Jong; Marco W Fraaije
Journal:  ACS Synth Biol       Date:  2022-01-19       Impact factor: 5.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.